You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

advanced Non-resectable melanoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma Trial in Norway (BGB324+pembrolizumab, BGB324+dabrafenib and trametinib, pembrolizumab)

Active, not recruiting
  • Melanoma
  • Bergen, Norway
  • +4 more
Aug 24, 2022

NSCLC, Melanoma Trial (IMM60, Pembrolizumab)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Melanoma
  • (no location specified)
Jan 24, 2023

Malignant Melanoma Trial in Germany (Dabrafenib, Trametinib)

Terminated
  • Malignant Melanoma
  • Heidelberg, BW, Germany
  • +5 more
Oct 13, 2020

Cutaneous Melanoma Trial in Houston (Atezolizumab)

Recruiting
  • Cutaneous Melanoma
  • Houston, Texas
    Houston Methodist Hospital
Dec 28, 2021

Non-Small Cell Bronchopulmonary Carcinoma or Melanoma Trial in Nice (18FDG PET)

Recruiting
  • Non-Small Cell Bronchopulmonary Carcinoma or Melanoma
  • 18FDG PET
  • Nice, France
    Centre Antoine Lacassagne
Sep 13, 2022

Cutaneous Melanoma, NSCLC, Colorectal Tumors Trial in Denver (SGN-BB228)

Recruiting
  • Cutaneous Melanoma
  • +4 more
  • Denver, Colorado
    Sarah Cannon Research Institute at HealthONE - Denver
Jan 17, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +41 more
  • Ipilimumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 11, 2022

Melanoma, NSCLC, Colorectal Cancer Trial in United States (LYL845)

Recruiting
  • Melanoma
  • +2 more
  • LYL845
  • Columbus, Ohio
  • +3 more
Dec 19, 2022

Locally Advanced Alveolar Soft Part Sarcoma, Metastatic Alveolar Soft Part Sarcoma, Locally Advanced Non Small Cell Lung Cancer

Not yet recruiting
  • Locally Advanced Alveolar Soft Part Sarcoma
  • +9 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 10, 2023

Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours Trial in Worldwide (lanreotide, Placebo)

Terminated
Has Results
  • Metastatic/Locally Advanced, Non-resectable, Duodeno-pancreatic Neuroendocrine Tumours
  • Bruxelles, Belgium
  • +23 more
Dec 21, 2022

NSCLC Stage IV, Melanoma Stage IV, Unresectable Melanoma Trial in Montréal (Camu Camu Capsules (Camu Camu powder encapsulated

Recruiting
  • NSCLC Stage IV
  • +3 more
  • Camu Camu Capsules (Camu Camu powder encapsulated (500mg each) + ICI
  • Montréal, Quebec, Canada
    Centre hospitalier de l'Université de Montréal (CHUM)
Jul 18, 2022

Non Small Cell Lung Cancer, Triple Negative Breast Cancer, Hodgkin Lymphoma Trial (CTX-8371)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +4 more
  • (no location specified)
Dec 4, 2023

Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Malignant Solid Tumor Trial in Sacramento

Recruiting
  • Advanced Colorectal Carcinoma
  • +15 more
  • Fermented Wheat Germ Extract
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Jul 26, 2023

Cholangiocarcinoma Non-resectable Trial in Chengdu (Candonilimab, Cisplatin, Gemcitabine)

Recruiting
  • Cholangiocarcinoma Non-resectable
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Aug 4, 2023

Non-melanoma Skin Cancer, Basal Cell Carcinoma, Squamous Cell Carcinoma Trial in Zurich (Talimogene Laherparepvec (T-VEC))

Completed
  • Non-melanoma Skin Cancer
  • +4 more
  • Talimogene Laherparepvec (T-VEC)
  • Zurich, Switzerland
    Department of Dermatology, University Hospital Zurich
Mar 17, 2022

Non Small Cell Lung Cancer Metastatic, Advanced Melanoma Trial in Toronto, Montréal, Québec (FMT + ICI)

Recruiting
  • Non Small Cell Lung Cancer Metastatic
  • Advanced Melanoma
  • FMT + ICI
  • Toronto, Ontario, Canada
  • +3 more
Aug 19, 2022

Nivolumab Monotherapy or in Combination With Ipilimumab in

Active, not recruiting
  • Melanoma
    • Essen, Germany
      Local Institution
    Apr 25, 2022

    Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • +13 more
    • (no location specified)
    Aug 29, 2023

    Patterns for Immunotherapy Agents and BRAF/MEK Inhibitors Used

    Completed
    • Melanoma
    • Non-Interventional
    • Boston, Massachusetts
      Local Institution
    Jan 27, 2022

    The Tumor Microenvironment for Locally Advanced Resectable

    Recruiting
    • Gastric Adenocarcinoma
    • Gastroesophageal Junction Adenocarcinoma
    • non-intervention
    • Guangzhou, Guangdong, China
      Nanfang Hospital, Southern Medical University
    Mar 24, 2022

    Melanoma, Glioma, Thyroid Cancer Trial (PF-07799544, PF-07284890, PF-07799933)

    Not yet recruiting
    • Melanoma
    • +6 more
    • (no location specified)
    Sep 9, 2022

    Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, Non-Melanoma Skin Cancers Trial in United States (IFx-Hu2.0)

    Recruiting
    • Merkel Cell Carcinoma
    • +2 more
    • IFx-Hu2.0
    • Los Angeles, California
    • +3 more
    Apr 4, 2022

    Advanced Non Small Cell Lung Cancer Trial in Changsha (Toripalimab combination with platinum-containing dual-drug chemo)

    Recruiting
    • Advanced Non Small Cell Lung Cancer
    • Toripalimab combination with platinum-containing dual-drug chemotherapy
    • Changsha, Hunan, China
      Hunan Provincal Tumor Hospital
    Dec 28, 2021

    Hepatocellular Carcinoma Non-resectable Trial in Guangzhou (Sin-Bev-TACE, Len-TACE)

    Recruiting
    • Hepatocellular Carcinoma Non-resectable
    • Guangzhou, Guangdong, China
      the Second Affiliated Hospital of Guangzhou Medical University
    Aug 2, 2023

    Integrated Molecular Profiling in Advanced Cancers Trial

    Active, not recruiting
    • Breast Cancer
    • +9 more
      • Toronto, Ontario, Canada
        Princess Margaret Hospital
      Sep 26, 2022